🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)
China flag China · Delayed Price · Currency is CNY
21.81
-1.59 (-6.79%)
Nov 20, 2026, 3:04 PM CST

SHE:002317 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
2,0862,5072,4442,6002,6652,416
Other Revenue
15.4915.4923.3510.3910.7212.74
2,1022,5232,4672,6112,6762,429
Revenue Growth
-14.14%2.24%-5.48%-2.45%10.17%28.13%
Cost of Revenue
952.61,1121,1351,081941.57813.75
Gross Profit
1,1491,4111,3321,5291,7351,615
Selling, General & Admin
887.951,0131,0021,0461,1721,086
Research & Development
82.7691.03111.2127.37156.59136.73
Other Operating Expenses
13.0213.528.4911.4924.1424.06
Operating Expenses
975.761,1251,1251,1831,3541,247
Operating Income
173.63285.75206.95346.21380.45368.16
Interest Expense
-2.81-5-25.35-46.91-73.36-73.81
Interest & Investment Income
17.5625.4443.6454.1473.9846.75
Currency Exchange Gain (Loss)
1.621.62-1.40-10.65-0.79
Other Non Operating Income (Expenses)
5.220.84-1.22-2.28-2.770.81
EBT Excluding Unusual Items
195.23308.65222.61351.16367.64341.12
Impairment of Goodwill
---201.68---
Gain (Loss) on Sale of Investments
-37.65-19.49-18.22-65.23-19.51-66.73
Gain (Loss) on Sale of Assets
10.796.050.0321.6814.69-0.63
Asset Writedown
23.36-18.79-299.21-30.56-2.83-2.22
Other Unusual Items
20.1720.17-39.416.68.337.94
Pretax Income
211.89296.59-335.88283.66368.3309.48
Income Tax Expense
11.4929.8838.0833.7652.9534.81
Earnings From Continuing Operations
200.4266.7-373.96249.9315.35274.67
Minority Interest in Earnings
1.369.0574.8113.376.72.96
Net Income
201.76275.75-299.16263.27322.05277.63
Net Income to Common
201.76275.75-299.16263.27322.05277.63
Net Income Growth
----18.25%16.00%-
Shares Outstanding (Basic)
840836831823805793
Shares Outstanding (Diluted)
840836831823805793
Shares Change
0.29%0.56%1.00%2.19%1.50%-1.45%
EPS (Basic)
0.240.33-0.360.320.400.35
EPS (Diluted)
0.240.33-0.360.320.400.35
EPS Growth
----20.00%14.29%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
471.97-10.97109.58-172.44-204.89409
Free Cash Flow Per Share
0.56-0.010.13-0.21-0.250.52
Dividend Per Share
0.2000.2000.2000.2000.2000.200
Dividend Growth
0%0%0%0%0%0%
Gross Margin
54.68%55.92%53.99%58.58%64.82%66.50%
Operating Margin
8.26%11.33%8.39%13.26%14.22%15.16%
Profit Margin
9.60%10.93%-12.12%10.08%12.03%11.43%
Free Cash Flow Margin
22.45%-0.43%4.44%-6.61%-7.66%16.84%
EBITDA
284.44401.53329.38465.05477.9462.45
EBITDA Margin
13.53%15.92%13.35%17.81%17.86%19.04%
D&A For EBITDA
110.8115.79122.43118.8497.4594.29
EBIT
173.63285.75206.95346.21380.45368.16
EBIT Margin
8.26%11.33%8.39%13.26%14.22%15.16%
Effective Tax Rate
5.42%10.08%-11.90%14.38%11.25%
Revenue as Reported
2,1022,5232,4672,6112,6762,429
Advertising Expenses
-46.0915.45.96.396.79